10085-RT-2 TREATMENT RESULTS OF AVAGAMMA THERAPY FOR RECURRENT GLIOBLASTOMA COMBINED WITH GAMMA KNIFE AND BEVACIZUMAB

Kenichi Sato, Taku Asanome, Yuuki Ishida, Ryuunosuke Yoshihara, Hironori Sugio, Masami Takanashi, Hirohiko Nakamura · 2023

Read 10085-RT-2 TREATMENT RESULTS OF AVAGAMMA THERAPY FOR RECURRENT GLIOBLASTOMA COMBINED WITH GAMMA KNIFE AND BEVACIZUMAB by Kenichi Sato, Taku Asanome, Yuuki Ishida, Ryuunosuke Yoshihara, Hironori Sugio, Masami Takanashi, Hirohiko Nakamura (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10710606.txt.

Description

Kenichi Sato and co-authors report, in a 2023 conference abstract, results for a combined salvage therapy in brain tumors that came back. The therapy, called AVAgamma, pairs a focused radiation method, gamma knife, with a drug that starves tumors of blood supply. Sixty-four patients with recurrent glioblastoma were treated after their first-line care failed. Results were set against thirty past patients who got radiation alone at relapse.

Time without growth after the combined therapy ran a median of six months, and median survival ten months. Survival from first treatment reached twenty-five months, ahead of twenty-one for radiation alone, though the gap fell short of firm statistical proof. Five-year survival also ran higher with the combo, above all in patients who were still in good shape at relapse. The authors credit the drug with better local control.

Catalog record

CREATORKenichi Sato, Taku Asanome, Yuuki Ishida, Ryuunosuke Yoshihara, Hironori Sugio, Masami Takanashi, Hirohiko Nakamura
YEAR2023
COLLECTIONPAPERS
FORMATTXT
FILE SIZE2 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC10710606

Browse the full library · About the Tower of Babel